DRACP05611 |
C16NTD |
XGLFGXGRKKRRQRRRPPQ |
19 |
Amidation |
DRACP05612 |
IRQ |
IRQRRRR |
7 |
Conjugation to solid lipid nanoparticle |
DRACP05613 |
CSK |
CSKSSDYQC |
9 |
Conjugation to solid lipid nanoparticle |
DRACP05614 |
R8-RGD-lipo |
RRRRRRRRRGDfK |
13 |
Free |
DRACP05615 |
Single mitochondrial penetrating peptide |
XFrFKFrFK |
9 |
Amidation |
DRACP05616 |
probe1 |
MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR |
33 |
Free |
DRACP05617 |
probe2 |
MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR |
33 |
Free |
DRACP05618 |
probe3 |
MGVADLIKKFESISKEEGGGGKXGGrRrRrRRR |
33 |
Free |
DRACP05619 |
Tat2-Nat |
RKKRRQRRRRKKRRQRRR |
18 |
Natamycin |
DRACP05620 |
MTat2-Nat |
AKKRRQRRRAKKRRQRRR |
18 |
Natamycin |
DRACP05621 |
TAT-LP-PTX |
CAYGRKKRRQRRR |
13 |
Rhodamine LP |
DRACP05622 |
T7-LP |
CHAIYPRH |
8 |
Rhodamine LP |
DRACP05623 |
TP |
GWTLNSAGYLLGKINLKALAALAKKIL |
27 |
Amidation |
DRACP05624 |
TP-biot1 |
GWTLNSAGYLLGKINLKALAALAKKIL |
27 |
Amidation |
DRACP05625 |
TP-biot13 |
GWTLNSAGYLLGXINLKALAALAKKIL |
27 |
Amidation |
DRACP05626 |
MTpl-1 |
KWSFRVSYRGISYRRSRGK |
19 |
Free |
DRACP05627 |
MTpl-2 |
KWFRVYRGIYRRRGK |
15 |
Free |
DRACP05628 |
MTpl-3 |
KWCFAVCYAGICYAACAGK |
19 |
|
DRACP05629 |
cTAT-GFP |
rRrGrKkRr |
9 |
GFP |
DRACP05630 |
TAT-GFP |
rRrGrKkRr |
9 |
GFP |
DRACP05631 |
V1 |
RRGRRG |
6 |
Amidation |
DRACP05632 |
5-FAM-H3R8 |
HHHRRRRRRRR |
11 |
Free |
DRACP05633 |
MTS-(5-FAM)- H3R8 |
HHHRRRRRRRR |
11 |
Free |
DRACP05634 |
CF-TAT-substrate |
YGRKKRRQRRREILSRXPAYRKIL |
24 |
Free |
DRACP05635 |
Ac-TAT-substrate |
YGRKKRRQRRREILSRXPAYRKIL |
24 |
Free |
DRACP05636 |
CF-Penetratin-substrate |
KKWKMRRNQFWIKIQREILSRXPAYRKIL |
29 |
Free |
DRACP05637 |
Ac-Penetratin-substrate |
KKWKMRRNQFWIKIQREILSRXPAYRKIL |
29 |
Free |
DRACP05638 |
fTAT |
CKYGRKKRRQRRR |
13 |
Free |
DRACP05639 |
dfTAT |
RRRQRRKKRGYCKCKYGRKKRRQRRR |
26 |
Free |
DRACP05640 |
acFTAT |
CKYGRKKRRQRRR |
13 |
Free |